Dr. Reddy's Laboratories Ltd. and Bristol Myers Squibb’s Celgene have reached a settlement agreement in patent-litigation proceedings stemming from the Indian firm’s development of a generic version of the originator’s Pomalyst (pomalidomide) capsules.
A letter penned by counsel representing both firms directs a US district court in New Jersey to dismiss the case...





